The American Journal of Surgery
Volume 196, Issue 4 , Pages 490-494 , October 2008

Internal mammary sentinel node biopsy for breast cancer

Received 16 April 2008 ,Revised 3 June 2008

References 

  1. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2004 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2007;
  2. Stibbe E. The internal mammary lymphatic glands. J Anat. 1918;52:257–259
  3. Turner-Warwick R. The lymphatics of the breast. Br J Surg. 1958;46:574–582
  4. Uren RF, Howman-Giles RB, Thompson JF, et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med. 1995;36:1775–1783
  5. Byrd D, Dunnwald LK, Mankoff DA, et al. Internal mammary lymph node drainage patterns in patients with breast documented by lymphoscintigraphy. Ann Surg Oncol. 2001;8:234–240
  6. Cody HS, Urban JA. Internal mammary node status: a major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol. 1995;2:32–37
  7. Noguchi M, Koyasaki N, Ohta N, et al. Internal mammary nodal status is a more reliable prognostic factor than DNA ploidy and c-erb B-2 expression in patients with breast cancer. Arch Surg. 1993;128:242–246
  8. Valagussa P, Bonadonna P, Veronesi U. Patterns of relapse and survival following radical mastectomy: analysis of 716 consecutive patients. Cancer. 1978;41:1170–1177
  9. Noguchi M, Ohta N, Thomas M, et al. Risk of internal mammary lymph node metastases and its prognostic value in breast cancer patients. J Surg Oncol. 1993;52:26–30
  10. Sugg SL, Ferguson DJ, Posner MC, et al. Should internal mammary nodes be sampled in the sentinel lymph node era?. Ann Surg Oncol. 2000;7:188–192
  11. Lohrisch C, Jackson J, Jones A, et al. Relationship between tumor location and relapse in 6781 women with early invasive breast cancer. J Clin Oncol. 2000;18:2828–2835
  12. Zucali R, Mariani L, Marubini E, et al. Early breast cancer: evaluation of the prognostic role of the site of the primary tumor. J Clin Oncol. 1998;16:1363–1366
  13. Leidenius MH, Krogerus LA, Toivonen TS, et al. The clinical value of parasternal sentinel node biopsy in breast cancer. Ann Surg Oncol. 2006;13:321–326
  14. Victorzon M, Hamalainen E, Svartback M, et al. Extra-axillary sentinel node biopsy in breast cancer staging: is it necessary?. Eur J Surg Oncol. 2003;29:604–606
  15. Bevilacqua JLB, Gucciardo G, Cody HS, et al. A selection algorithm for internal mammary sentinel lymph node biopsy in breast cancer. Eur J Surg Oncol. 2002;28:603–614
  16. Paganelli G, Galimberti V, Trifiro G, et al. Internal mammary node lymphoscintigraphy and biopsy in breast cancer. Q J Nucl Med. 2002;46:138–144
  17. Park C, Seid P, Morita E, et al. Internal mammary sentinel lymph node mapping for invasive breast cancer: implications for staging and treatment. Breast J. 2005;11:29–33
  18. Shimazu K, Tamaki Y, Taguchi T, et al. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer. Ann Surg. 2003;237:390–398
  19. Mudun A, Sanli Y, Ozmen V, et al. Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience. Clin Nucl Med. 2008;33:262–267

PII: S0002-9610(08)00452-2

doi: 10.1016/j.amjsurg.2008.06.003

The American Journal of Surgery
Volume 196, Issue 4 , Pages 490-494 , October 2008

Article Tools